Cytotoxicity of Methylsulfonylmethane on Gastrointestinal (AGS, HepG2, and KEYSE-30) Cancer Cell Lines
- 28 May 2011
- journal article
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 43 (3) , 420-425
Abstract
This study was conducted to assay cytotoxic effects of methylsulfonylmethane (MSM) on gastrointestinal cancer cell lines. Human gastric carcinoma (AGS), human hepatocellular carcinoma (HepG2), and human esophageal squamous cell carcinoma (KYSE-30) cancer cell lines were treated by MSM and incubated for 24, 48, and 72 h. Cytotoxicity was examined through MTT, neutral red uptake, and protein measurement assays. Ethidium bromide/acridine orange (EB/AO) staining was used for apoptotic cell detection. A diamidino-2-phenylindole staining method was used to analysis cell cycle by flow cytometry. IC50 of MSM on AGS, HepG2, and KYSE-30 cell lines were 28.04, 21.87 and 27.98 mg/ml after 72 h, respectively. The EB/AO staining showed an increase in apoptotic cells. Cell cycle analysis showed a significant increase in cell density at G2/M phase. MSM had cytotoxic effect on cancer cell lines but HepG2 cell line was more susceptible. This study suggests that MSM may induce cytotoxic effect on gastrointestinal cancer cell lines by apoptosis and cell cycle arrest.Keywords
This publication has 20 references indexed in Scilit:
- Epidemiology, risk factors and surveillance of hepatocellular carcinoma.2010
- Epidemiology of gastric cancerWorld Journal of Gastroenterology, 2006
- A simple technique for quantifying apoptosis in 96-well platesBMC Biotechnology, 2005
- Distinct roles for p53 transactivation and repression in preventing UCN-01-mediated abrogation of DNA damage-induced arrest at S and G2 cell cycle checkpointsOncogene, 2005
- Aspirin and methylsulfonylmethane (MSM): a search for common mechanisms, with implications for cancer prevention.2003
- A Multicentered, Open-Label Trial on the Safety and Efficacy of Methylsulfonylmethane in the Treatment of Seasonal Allergic RhinitisThe Journal of Alternative and Complementary Medicine, 2002
- Polar Solvents in the Chemoprevention of Dimethylbenzanthracene-Induced Rat Mammary CancerArchives of Surgery, 1986
- Effects of Oral Dimethyl Sulfoxide and Dimethyl Sulfone on Murine Autoimmune Lymphoproliferative DiseaseExperimental Biology and Medicine, 1986
- Dimethyl sulfoxide as a cholesterol-lowering agent in cultured fibroblasts exposed to low density lipoproteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1982
- Susceptibility of Friend Erythroleukemia Cells to Natural Cytotoxicity after In Vitro Treatment with Dimethyl SulfoxideExperimental Biology and Medicine, 1982